mebeverine has been researched along with Experimental Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akagi, K; Futakuchi, M; Hirose, M; Hoshiya, T; Ito, N | 1 |
Kadowaki, H; Kimura, S; Miwa, T; Otaka, T; Shimizu, Y; Takahashi, T; Tamagawa, M; Uda, F | 1 |
Kimura, S; Miwa, T; Otaka, T; Otaki, Y; Takahashi, T; Tamagawa, M | 1 |
Fukushima, S; Hirose, M; Ito, N; Ozaki, K; Shirai, T; Takaba, K | 1 |
4 other study(ies) available for mebeverine and Experimental Neoplasms
Article | Year |
---|---|
Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[alpha]anthracene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antioxidants; Catechols; Ear Neoplasms; Female; Hydrolyzable Tannins; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Phenylpropionates; Phytic Acid; Rats; Rats, Sprague-Dawley; Tea | 1994 |
Carcinogenicity study of gamma-oryzanol in F344 rats.
Topics: Administration, Oral; Animals; Body Weight; Carcinogens; Dose-Response Relationship, Drug; Female; Hypolipidemic Agents; Male; Neoplasms, Experimental; Organ Size; Phenylpropionates; Rats; Rats, Inbred F344 | 1992 |
Carcinogenicity study of gamma-oryzanol in B6C3F1 mice.
Topics: Administration, Oral; Animals; Body Weight; Carcinogens; Dose-Response Relationship, Drug; Female; Hypolipidemic Agents; Male; Mice; Neoplasms, Experimental; Organ Size; Phenylpropionates | 1992 |
Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model.
Topics: Adenoma; Aminobiphenyl Compounds; Animals; Body Weight; Carcinogenicity Tests; Carcinoma, Hepatocellular; Hydrolyzable Tannins; Hyperplasia; Hypolipidemic Agents; Kidney; Liver; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Neoplasms, Experimental; Organ Size; Pancreatic Neoplasms; Papilloma; Paraffin; Phenylpropionates; Phytic Acid; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1991 |